JPRN-UMIN000023574已完成未知
The pilot study of SGLT2 selective inhibitor therapy for NAFLD patients who were complicated with T2DM - The pilot study of SGLT2 selective inhibitor therapy for NAFLD patients who were complicated with T2DM
Department of Hepatology, Shimane University Hospital0 个研究点目标入组 20 人开始时间: 2016年8月9日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Chronic liver disease cases other than the non-alcoholic fatty liver disease.
研究者
相似试验
招募中
4 期
Efficacy of SGLT2 inhibitor for Non-Alcoholic Fatty Liver Diseaseon Alcoholic Fatty Liver DiseaseC06.552.241.519C18.452.394.750.149ObesityType 2 Diabetes MellitusRBR-48rxwbCentro Educacional Hyarte
已完成
Unknown
Prospective observational study of tofogliflozin in patients with type 2 diabetesType 2 DiabetesJPRN-jRCT1090220212agoya Medical Association600
已完成
不适用
Prospective intervention study of novel SGLT-2 inhibitor ipragliflozin in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000015104Seino Naika Clinic100
招募中
不适用
Efficacy of the selective SGLT2 Inhibitor for Glycogen Storage Disease Type 1bGlycogen Storage Disease type 1bCarbohydrate Metabolism, Inborn ErrorsD005953JPRN-jRCTs071210064akanishi Koichi5
招募中
不适用
The clinical study to explore the effects of SGLT2-inhibitors or DPP-4 inhibitors in Japanese patients with type 2 diabetes.Type 2 diabetesJPRN-UMIN000020984Showa University School of Medicine, Division of Diabetes and Endocrinology, Department of Internal Medicine160